Elevated PSA – What To Do
Timeline
Video Summary
Prostate-specific antigen (PSA) is a blood marker produced by prostate tissue and commonly used in prostate health screening. An elevated PSA does not automatically indicate prostate cancer, as levels can rise due to benign prostatic hyperplasia, prostatitis, recent ejaculation, or medical procedures. The video emphasizes avoiding panic and instead taking a structured approach.
Evaluation of an elevated PSA begins with confirming the result and reviewing contributing factors such as infections, medications, urinary symptoms, and recent activities. PSA trends over time are often more informative than a single value. The discussion highlights the importance of repeat testing, free PSA, and risk stratification before invasive steps.
Management decisions may include observation, further blood tests, imaging such as prostate MRI, or referral to urology when appropriate. The goal is to identify clinically significant disease while minimizing unnecessary biopsies and anxiety. Shared decision-making and individualized risk assessment are central themes.
Drug Callouts
Condition Callouts
Key Takeaways
- An elevated PSA does not automatically mean prostate cancer.
- Benign conditions commonly raise PSA levels.
- PSA trends over time provide more insight than a single test.
- Stepwise evaluation reduces unnecessary biopsies.
- Shared decision-making improves outcomes and reduces anxiety.